BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 2, 2011
View Archived Issues
Phase II study assesses BAF-312 in relapsing-remitting MS
Read More
Imaging agent [123I]-BZM-055 assessed in nonhuman primates
Read More
Lostam BioPharmaceutical presents monoclonal antibodies against P. aeruginosa flagellin
Read More
Scientists in Sweden identify new biomarker for disease activity in MS
Read More
Natural plant-derived product inhibits proliferation of gastric cancer cells
Read More
Novel sterol O-acyltransferase 2 inhibitors synthesized in Japan
Read More
New HIV integrase inhibitors presented by Critical Outcome Technologies
Read More
Johnson & Johnson submits sNDA to FDA for Nucynta ER
Read More
Circadian Technologies clear to start clinical development of VGX-100
Read More
Actelion Pharmaceuticals discloses novel antibacterials
Read More
Sanofi presents new Met inhibitors
Read More
Galena Biopharma focuses on late-stage targeted cancer drug development
Read More
Piramal Life Sciences synthesizes new cytokine inhibitors
Read More
Takeda Pharmaceutical prepares novel histamine H3 receptor antagonists
Read More
TNF-Kinoid shows promise in phase IIa trial
Read More
CytRx reports further on phase Ib/II study of INNO-206
Read More
FDA approves Pacira Pharmaceuticals' Exparel
Read More
European orphan drug status for Celldex Therapeutics' rindopepimut
Read More
Takara Bio to develop gene therapy for non-Hodgkin's lymphoma
Read More
MorphoSys and Shionogi extend HuCAL research partnership
Read More
Phase II study of CK-2017357 advances
Read More
NVB-302 enters clinical testing
Read More
Infinity Pharmaceuticals begins two studies of IPI-145
Read More
FDA approves Xience Prime stent
Read More
Avanir Pharmaceuticals submits MAA for Nuedexta
Read More